ANI Pharmaceuticals | ANIP - Ação





Ação Alterar Data
AbbVie USD 5.13B 78M 2026-06
ANI Pharmaceuticals USD 143.15M 319K 2026-06
Aurora Cannabis CAD 175.08M 55.48M 2026-03
Canopy Growth CAD 110.51M 4.96M 2026-03
Eli Lilly USD 16.79B 2.26B 2026-06
Emergent BioSolutions USD 328.9M 25.2M 2023-12
Heron Therapeutics USD 54.57M 2.33M 2022-12
Hikma Pharmaceutical USD 1.11B 24M 2025-12
Knight Therapeutics CAD 95.4M 2.91M 2024-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.29B 135M 2026-03
Omeros USD 712K 266K 2021-09
Perrigo USD 1.06B 56.9M 2026-06
Sun Pharmaceuticals INR 114.93B 12.5B 2026-03
Teva Pharmaceutical Industries USD 3.18B 3M 2026-03